SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries during two international medical conferences in October 2026. The demonstrations underscore the growing feasibility of remote robotic surgery and its potential to bridge gaps in surgical expertise across geographies.
At the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient in Bengaluru, India, approximately 7,500 miles away. The procedure highlighted the SSi MantrAsana console’s ability to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization, and precise instrument control. At the Society of Robotic Surgery India (SRS India) Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries involving kidney, colorectal, pediatric urological, and gynecological procedures.
As of Oct. 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. The milestone suggests that telesurgery is moving from experimental demonstrations toward broader clinical adoption, which could have significant implications for patients in underserved regions where specialized surgical expertise is scarce.
The SSi Mantra system is a modular, multi-arm robotic platform with advanced features such as 3 to 5 robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and a touch panel monitor for patient-related information. It utilizes over 40 different types of robotic endo-surgical instruments to support various specialties, including cardiac surgery, and 5mm instruments for pediatric and ENT surgeries. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the standard command center, intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.
SS Innovations, headquartered in India but a U.S. company, aims to make robotic surgery affordable and accessible to a larger segment of the global population. For more information, visit ssinnovations.com or its LinkedIn page. The full press release is available at https://ibn.fm/Ujtlm, and the company’s newsroom can be found at https://ibn.fm/SSII.
The announcement was distributed via TechMediaWire, a specialized communications platform within the Dynamic Brand Portfolio at IBN. TechMediaWire provides access to wire solutions through InvestorWire, along with editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For full terms of use and disclaimers, visit https://www.TechMediaWire.com/Disclaimer.
